(Q46300973)

English

Will a new intravesical chemotherapy agent improve the treatment of non-muscle-invasive bladder cancer?

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

Will a new intravesical chemotherapy agent improve the treatment of non-muscle-invasive bladder cancer? (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

author name string

Eila Skinner

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

language of work or name

0 references

publication date

27 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

Nature Reviews Urology

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

248-249

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

The treated natural history of high risk superficial bladder cancer: 15-year outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0762

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0762

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0762

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0762

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NCPURO0762

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/17389884

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46300973&oldid=2207787286"